Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 1
2000 1
2002 1
2003 2
2004 2
2005 4
2006 3
2007 4
2008 3
2010 4
2011 5
2012 2
2013 5
2015 3
2016 3
2017 4
2018 6
2019 6
2020 4
2021 4
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

63 results

Results by year

Filters applied: . Clear all
Page 1
The Adjuvanted Recombinant Zoster Vaccine Confers Long-Term Protection Against Herpes Zoster: Interim Results of an Extension Study of the Pivotal Phase 3 Clinical Trials ZOE-50 and ZOE-70.
Boutry C, Hastie A, Diez-Domingo J, Tinoco JC, Yu CJ, Andrews C, Beytout J, Caso C, Cheng HS, Cheong HJ, Choo EJ, Curiac D, Di Paolo E, Dionne M, Eckermann T, Esen M, Ferguson M, Ghesquiere W, Hwang SJ, Avelino-Silva TJ, Kosina P, Liu CS, Markkula J, Moeckesch B, Murta de Oliveira C, Park DW, Pauksens K, Pirrotta P, Plassmann G, Pretswell C, Rombo L, Salaun B, Sanmartin Berglund J, Schenkenberger I, Schwarz T, Shi M, Ukkonen B, Zahaf T, Zerbini C, Schuind A, Cunningham AL; Zoster-049 Study Group. Boutry C, et al. Among authors: kosina p. Clin Infect Dis. 2022 Apr 28;74(8):1459-1467. doi: 10.1093/cid/ciab629. Clin Infect Dis. 2022. PMID: 34283213 Free PMC article. Clinical Trial.
[Invasive streptococcal infections].
Kosina P, Plísek S, Dostál V, Morávková M, Cermák P, Preis J, Lukes A, Kracmarová R, Krausová J. Kosina P, et al. Klin Mikrobiol Infekc Lek. 2007 Dec;13(6):220-4. Klin Mikrobiol Infekc Lek. 2007. PMID: 18320500 Review. Czech.
UVA-photoprotective potential of silymarin and silybin.
Rajnochová Svobodová A, Gabrielová E, Michaelides L, Kosina P, Ryšavá A, Ulrichová J, Zálešák B, Vostálová J. Rajnochová Svobodová A, et al. Among authors: kosina p. Arch Dermatol Res. 2018 Jul;310(5):413-424. doi: 10.1007/s00403-018-1828-6. Epub 2018 Mar 21. Arch Dermatol Res. 2018. PMID: 29564550
Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota.
Valentová K, Havlík J, Kosina P, Papoušková B, Jaimes JD, Káňová K, Petrásková L, Ulrichová J, Křen V. Valentová K, et al. Among authors: kosina p. Metabolites. 2020 Jan 9;10(1):29. doi: 10.3390/metabo10010029. Metabolites. 2020. PMID: 31936497 Free PMC article.
Skin Protective Activity of Silymarin and its Flavonolignans.
Vostálová J, Tinková E, Biedermann D, Kosina P, Ulrichová J, Rajnochová Svobodová A. Vostálová J, et al. Among authors: kosina p. Molecules. 2019 Mar 14;24(6):1022. doi: 10.3390/molecules24061022. Molecules. 2019. PMID: 30875758 Free PMC article.
The Phototoxic Potential of the Flavonoids, Taxifolin and Quercetin.
Rajnochová Svobodová A, Ryšavá A, Psotová M, Kosina P, Zálešák B, Ulrichová J, Vostálová J. Rajnochová Svobodová A, et al. Among authors: kosina p. Photochem Photobiol. 2017 Oct;93(5):1240-1247. doi: 10.1111/php.12755. Epub 2017 Apr 27. Photochem Photobiol. 2017. PMID: 28303596
Disposition of sanguinarine in the rat.
Vecera R, Klejdus B, Kosina P, Orolin J, Stiborová M, Smrcek S, Vicar J, Dvorák Z, Ulrichová J, Kubán V, Anzenbacher P, Simánek V. Vecera R, et al. Among authors: kosina p. Xenobiotica. 2007 May;37(5):549-58. doi: 10.1080/00498250701230542. Xenobiotica. 2007. PMID: 17523056
Antioxidant properties of silybin glycosides.
Kosina P, Kren V, Gebhardt R, Grambal F, Ulrichová J, Walterová D. Kosina P, et al. Phytother Res. 2002 Mar;16 Suppl 1:S33-9. doi: 10.1002/ptr.796. Phytother Res. 2002. PMID: 11933137
63 results